About Taffic Tablet
Taffic Tablet contains Bictegravir, Emtricitabine, and Tenofovir Alafenamide, a combination antiretroviral medicine used to treat HIV-1 infection by reducing the amount of virus in the body and helping strengthen the immune system. Do not take it if you are allergic to any of its ingredients, and inform your doctor if you have liver, kidney, bone, or pancreas problems, or a history of fractures or heart conditions. Regular monitoring of blood counts and organ function may be required during treatment. Some patients may experience immune reconstitution syndrome after starting therapy, so report any signs of worsening infections to your doctor. Effective contraception is advised during treatment, and breastfeeding is not recommended due to the risk of HIV transmission.
Targeted HIV Care with Taffic TabletTaffic Tablet brings together three powerful antiretrovirals-Bictegravir, Emtricitabine, and Tenofovir Alafenamide-to provide comprehensive therapy for HIV-1 infection. This advanced formulation aids in suppressing viral replication, supporting better health outcomes for patients.
Stability and Packaging You Can TrustEach box of Taffic Tablet contains 30 tablets, suitable for a month's medication cycle. The tablets must be stored below 30C to maintain their efficacy up to their expiration year, 2028. Careful packaging ensures the medicine remains secure and protected during transportation and storage.
Global Supply from India's Leading ExportersProduced and shipped from India, Taffic Tablet is available for export, supply, and trade to healthcare providers around the world. Extensive logistic networks ensure timely and efficient delivery, allowing uninterrupted access to essential HIV-1 management therapies.
FAQ's of Taffic Tablet:
Q: How should Taffic Tablet be taken for HIV-1 infection?
A: Taffic Tablet should be taken exactly as prescribed by your healthcare provider, typically once daily, with or without food. Consistency in taking the tablet each day is essential for maximizing its benefits and maintaining effective viral suppression.
Q: What are the active ingredients and their molecular formula in Taffic Tablet?
A: Taffic Tablet contains the antiretroviral agents Bictegravir, Emtricitabine, and Tenofovir Alafenamide. These work in combination to inhibit the replication of HIV-1 and reduce viral load in the body.
Q: When does Taffic Tablet expire, and how should it be stored?
A: Taffic Tablet has an expiration date set for the year 2028. It should be stored at room temperature, below 30C, and kept in its original packaging to maintain stability and efficacy until its expiration.
Q: Where is Taffic Tablet manufactured and supplied from?
A: Taffic Tablet is manufactured in India and supplied globally through certified exporters, suppliers, and traders, ensuring high standards in quality and distribution.
Q: What is the process for obtaining Taffic Tablet internationally?
A: International customers can acquire Taffic Tablet through authorized exporters and suppliers based in India. Orders are fulfilled by following proper medical and import regulations relevant to the destination country.
Q: What benefits does Taffic Tablet offer to patients with HIV-1 infection?
A: Taffic Tablet combines three potent antiretroviral agents in a single pill, offering convenience, improved adherence, and effective viral suppression, contributing to better long-term management of HIV-1 infection.
Q: Is there any special packaging or quantity per box for Taffic Tablet?
A: Each box of Taffic Tablet contains 30 tablets, providing a one-month supply per box. The packaging secures the tablets for protection during transit and storage.